Detalhe da pesquisa
1.
Clinical management of metastatic hormone receptor-positive, HER2-negative breast cancer (MBC) after CDK 4/6 inhibitors: a retrospective single-institution study.
Breast Cancer Res Treat
; 196(1): 229-237, 2022 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-36045271
2.
Tumor Mutational Burden Is a Potential Predictive Biomarker for Response to Immune Checkpoint Inhibitors in Patients With Advanced Biliary Tract Cancer.
JCO Precis Oncol
; 6: e2200003, 2022 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35772047
3.
64-Year-Old Female With Right Upper Quadrant Pain and Jaundice.
Mayo Clin Proc
; 98(6): 927-932, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37125975